JP Patent

JP7568800B2 — メロキシカム及びリザトリプタンを含有する固体医薬組成物並びにメロキシカム及びリザトリプタンを含有する医薬の製造におけるメロキシカム及びリザトリプタンの使用

Assigned to アクスサム セラピューティクス インコーポレイテッド · Expires 2024-10-16 · 2y expired

What this patent protects

Patent listed against Mobic.

Drugs covered by this patent

Patent Metadata

Patent number
JP7568800B2
Jurisdiction
JP
Classification
—
Expires
2024-10-16
Drug substance claim
No
Drug product claim
No
Assignee
アクスサム セラピューティクス インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.